NASDAQ · Biotechnology

ASBP (ASBP) Stock

$7.26 +3.13% NASDAQ: ASBP Healthcare

Valuation

MetricValue
Price$7.26
Market Cap$837601
P/E Ratio-0.74
P/B Ratio2.40
P/S Ratio20.73
EPS (TTM)$0.00
52-Week High$35.00
52-Week Low$0.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE199.43%
ROA-165.27%
ROCE-137.24%
Gross Margin0.00%
Operating Margin0.00%
Net Margin-340.40%
Debt/Equity0.13
Current Ratio0.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$-1.0M$-1.0M$-3.0M$-19.0M
Net Profit$0$3.0M$4.0M$-13.0M$-24.0M
EPS$-0.04$3.72$9.31$-18.17$-16.38
Op Margin————-312017.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$300.0M$20.0M$0$1.0M
Total Liabilities$0$11.0M$0$2.0M$8.0M
Cash$0$0$0$0$1.0M
Borrowings$0$0$0$1.0M$1.0M

Latest News

OTC Markets Life Sciences Investor Forum: Stephen Quesenberry, General Counsel and Director of Product Development, of Aspire Biopharma with Zacks SCR’s David Bautz, PhD Zacks Small Cap Research · Jul 10, 2026 Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing GlobeNewswire · Jun 26, 2026 Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs ACCESS Newswire · Jun 24, 2026 Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th GlobeNewswire · Jun 23, 2026 Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th GlobeNewswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$-1.0M$0$-5.0M
Investing Cash Flow$0$-295.0M$285.0M$0$0
Financing Cash Flow$0$0$-285.0M$-2.0M$-1.0M
Net Cash Flow$0$0$0$0$1.0M
Free Cash Flow$0$-1.0M$-1.0M$0$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-1.08
FCF Yield-866.83%
Quick Ratio2.14
Interest Coverage-0.55
Return 1Y-52.52%
Return 3Y-98.56%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANNA $3.06 -8.11% 80.25 $125.28M 0.00%
BOCNBlue Ocean Acquisition Corp. $10.72 — 46.59 $70.57M 0.00%
CAUDCollective Audience, Inc. $0.00 — 0.00 $20000 0.00%
CHAACatcha Investment Corp $8.90 +7.23% -18.94 $77.57M 0.00%
CSLMConsilium Acquisition Corp I, Ltd. $11.69 +0.00% 1.11 $71.50M 0.00%

About ASBP

ASBP is led by CEO Kraig T. Higginson, employs 2 people, headquartered in US, publicly traded since 2025.

ASBP stock trades at $7.26 with a market capitalization of $837601. The stock is valued at a price-to-earnings (P/E) ratio of -0.74, price-to-book of 2.40, price-to-sales of 20.73. Over the past 52 weeks the stock has ranged between $0.11 and $35.00, and currently trades 79.3% below its 52-week high.

On profitability, ASBP generates a return on equity (ROE) of 199.43% — well above the market average, a sign of a high-quality business, return on capital employed of -137.24%, an operating margin of 0.00%, a net profit margin of -340.40%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides